Cargando…

Rat mRNA expression profiles associated with inhibition of ischemic acute kidney injury by losartan

Objective: Losartan was reported to inhibit the progression of acute kidney injury (AKI), but little is known about the underlying pharmacological mechanisms. In the present study, the mRNA expression profiles in ischemic AKI rat kidney altered by losartan treatment were analyzed by next-generation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yijin, Peng, Wenying, Wei, Ru, Zhou, Yanhe, Fang, Miaoxian, Liu, Siyi, Deng, Yujun, Yin, Qi, Ouyang, Xin, Hu, Linhui, Hou, Yating, Chen, Chunbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454018/ https://www.ncbi.nlm.nih.gov/pubmed/30877184 http://dx.doi.org/10.1042/BSR20181774

Ejemplares similares

The effect of glucocorticoids on serum cystatin C in identifying acute kidney injury: a propensity-matched cohort study
por: Liang, Silin, et al.
Publicado: (2020)

Impact of thyroid function on cystatin C in detecting acute kidney injury: a prospective, observational study
por: Zhang, Danqing, et al.
Publicado: (2019)

Assessment of 17 clinically available renal biomarkers to predict acute kidney injury in critically ill patients
por: Hou, Yating, et al.
Publicado: (2021)

Impact of blood glucose levels on the accuracy of urinary N-acety-β-D-glucosaminidase for acute kidney injury detection in critically ill adults: a multicenter, prospective, observational study
por: Wang, Lin, et al.
Publicado: (2019)

The influence of glycemic status on the performance of cystatin C for acute kidney injury detection in the critically ill
por: Deng, Yujun, et al.
Publicado: (2019)

C-reactive protein concentration as a risk predictor of mortality in intensive care unit: a multicenter, prospective, observational study
por: Qu, Rong, et al.
Publicado: (2020)

Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m(6)A modification of Trio mRNA
por: Li, Jiaxin, et al.
Publicado: (2022)

Variations of urinary N-acetyl-β-D-glucosaminidase levels and its performance in detecting acute kidney injury under different thyroid hormones levels: a prospectively recruited, observational study
por: Liang, Silin, et al.
Publicado: (2022)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

The incidence, risk factors and outcomes of acute kidney injury in critically ill patients undergoing emergency surgery: a prospective observational study
por: Hu, Linhui, et al.
Publicado: (2022)

The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan
por: García Trejo, Ehécatl Miguel Ángel, et al.
Publicado: (2017)

Losartan: Hypotension and acute kidney injury: 7 case reports
Publicado: (2021)

Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review
por: Al-Halawani, Moh’d Z., et al.
Publicado: (2014)

Silencing CircHIPK3 Sponges miR-93-5p to Inhibit the Activation of Rac1/PI3K/AKT Pathway and Improves Myocardial Infarction-Induced Cardiac Dysfunction
por: Wu, Yijin, et al.
Publicado: (2021)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Gas embolism caused by gas-forming pyogenic liver abscess
por: Chen, Weisheng, et al.
Publicado: (2023)

Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury
por: Cheng, Shun-Yang, et al.
Publicado: (2016)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
por: Safari, Tahereh, et al.
Publicado: (2019)

A nomogram incorporating functional and tubular damage biomarkers to predict the risk of acute kidney injury for septic patients
por: Ma, Jianchao, et al.
Publicado: (2021)

Losartan Improved Antioxidant Defense, Renal Function and Structure of Postischemic Hypertensive Kidney
por: Ivanov, Milan, et al.
Publicado: (2014)

Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
por: Rahmani, Waleed, et al.
Publicado: (2022)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Effect of losartan on performance and physiological responses to exercise at high altitude (5035 m)
por: Lucas, Samuel J E, et al.
Publicado: (2021)

The Incidence, Risk Factors and Outcomes of Postoperative Acute Kidney Injury in Neurosurgical Critically Ill Patients
por: Deng, Yujun, et al.
Publicado: (2017)

Calcitriol reduces kidney development disorders in rats provoked by losartan administration during lactation
por: de Almeida, Lucas Ferreira, et al.
Publicado: (2017)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021)

Circulating mRNA and microRNA profiling analysis in patients with ischemic stroke
por: Sun, Sujuan, et al.
Publicado: (2020)

Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients
por: Lv, Bo, et al.
Publicado: (2021)

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
por: Nouri-Majalan, Nader, et al.
Publicado: (2009)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Integrated Analysis of Immune-Related circRNA-miRNA-mRNA Regulatory Network in Ischemic Stroke
por: Cao, Si, et al.
Publicado: (2022)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

A Case Report of Losartan Induced Angioedema
por: Vedantam, Venkata, et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Losartan-Induced Angioedema: A Case Report
por: Mann, Henry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q1nis04b4v20iteqdaijjucfhh